Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

COHANCE LIFESCIENCES LTD.

  • NSE CodeCOHANCEEQ
  • BSE Code543064
  • ISININE03QK01018
  • IndustryPharmaceuticals

Company Information

Management

Vivek Sharma

Executive Chairman

Incorporation Year

06/11/2018

Registered Address

Registered Office : 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala MIDC,
Mumbai, Maharashtra - 400093
Tel: 022-61539999
Fax: 022-23541152

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

info@suvenpharm.com

Website

http://www.suvenpharm.com

Listing

BSE, BSE, NSE

Corporate News

Cohance Lifesciences - Resignation of Director/KMP/SM...

18-Jun-2026|6:20PM

Cohance Lifesciences Limited has informed the Exchange about Resignation of

Cohance Lifesciences - Disclosures of reasons for enc...

18-Jun-2026|3:43PM

The Exchange has received the Disclosures of reasons for encumbrance by pro

Cohance Lifesciences - Announcement under Regulation ...

17-Jun-2026|10:33PM

Resignation of Mr. Himanshu Agarwal as Executive Director and Chief Financi

Cohance Lifesciences - Resignation

17-Jun-2026|10:32PM

Cohance Lifesciences Limited has informed the Exchange regarding Resignatio

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug90.00255.19
Aarti Drug374.503,418.06
Aarti Pharma719.156,519.65
Abbott India25,795.0054,812.57
Accent Micro464.451,114.17
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
ICICI P..282.164.37
SBI Mul..224.381.23
HDFC Ba..178.790.17
Invesco..173.200.89
DSP ELS..141.760.88
More

Board Meetings

DatePurpose
12/05/2026Audited Results
12/02/2026Quarterly Results
12/11/2025Quarterly Results
13/08/2025Quarterly Results
28/05/2025Audited Results
More